| scholarly article | Q13442814 |
| P2093 | author name string | J S Marks | |
| P2860 | cites work | Long-Term Course of Chloroquine Retinopathy after Cessation of Medication | Q28327416 |
| Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis | Q28364259 | ||
| Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year | Q33570833 | ||
| Chloroquine diphosphate in rheumatoid arthritis. A controlled trial | Q33570876 | ||
| Ophthalmological safety of chloroquine | Q33967103 | ||
| Weber-Christian disease.? a collagen disease | Q35795939 | ||
| Variations in the normal electro-oculogram | Q37337538 | ||
| Is chloroquine obsolete in treatment of rheumatic disease? | Q39534526 | ||
| OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE. | Q39838619 | ||
| Ring maculopathies mimicking chloroquine retinopathy | Q41932996 | ||
| Ocular toxicity of antimalarial drugs. Long-term follow-up | Q41939915 | ||
| Electrodiagnosis in drug-induced disorders of the eye. | Q41941642 | ||
| Chloroquine retinopathy. Evaluation by fluorescein fundus angiography | Q41941893 | ||
| Chloroquine retinopathy. Early detection by retinal threshold test | Q41942216 | ||
| Three cases of chloroquine retinopathy. A follow-up investigation | Q41942280 | ||
| The prevention of drug-induced retinopathies | Q41942339 | ||
| OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY | Q41942950 | ||
| COMING CATASTROPHES WITH CHLOROQUINE? | Q41943218 | ||
| OCULAR COMPLICATIONS OF CHLOROQUINE. A SERIES AND CASE PRESENTATION WITH A SIMPLE METHOD FOR EARLY DETECTION OF RETINOPATHY. | Q41943263 | ||
| THE PATHOLOGY OF CHLOROQUINE RETINOPATHY. | Q41943979 | ||
| EARLY CHLOROQUINE RETINOPATHY: CLINICAL AND FUNCTIONAL FINDINGS. | Q41943983 | ||
| CHLOROQUINE RETINOPATHY AND ITS INCIDENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS | Q41944075 | ||
| THE EOG IN CHLOROQUINE AND OTHER RETINOPATHIES. | Q41944336 | ||
| STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY. | Q41944384 | ||
| RETINAL DAMAGE IN CHLOROQUINE THERAPY | Q41944921 | ||
| Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings | Q41945009 | ||
| Bilateral Macular Degeneration Associated with Chloroquine Therapy* | Q41945107 | ||
| Chloroquine macular degeneration | Q41945142 | ||
| Anticipation of chloroquine retinopathy | Q41945190 | ||
| Electroretinographic examinations following the application of chloroquine | Q41945338 | ||
| Electroretinographic changes in chloroquine therapy | Q41945355 | ||
| Chloroquine retinopathy. A further case. | Q41945407 | ||
| Chloroquine (Aralen)-induced retinal damage | Q41945592 | ||
| Macular function and the photostress test 2 | Q72206508 | ||
| The scotometer. A device for measuring macular recovery time | Q72247135 | ||
| Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis | Q72756290 | ||
| Delayed Onset of Chloroquine Retinopathy | Q72797505 | ||
| Retinal damage by light in rats | Q72826346 | ||
| Unusual ocular lesions in a case of systemic lupus erythematosus | Q74435603 | ||
| Ocular abnormalities in patients treated with synthetic antimalarial drugs | Q76428819 | ||
| SCREENING TEST FOR CHLOROQUINE RETINOPATHY | Q76890694 | ||
| Retinopathy following chloroquine therapy | Q78766793 | ||
| Chloroquine Retinopathy | Q79009239 | ||
| Two Cases of Chloroquine-induced Retinal Damage | Q79041031 | ||
| Retinopathy associated with chloroquine | Q79656438 | ||
| Studies of the eye in old age; hole in the macula; a clinicopathologic study | Q80665737 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chloroquine | Q422438 |
| Chloroquine retinopathy | Q5103170 | ||
| P304 | page(s) | 52-8 | |
| P577 | publication date | 1982-02-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Chloroquine retinopathy: is there a safe daily dose? | |
| P478 | volume | 41 |
| Q41920359 | Antimalarial drugs for rheumatoid arthritis |
| Q41943683 | Chloroquine-induced bull's eye maculopathy in rheumatoid arthritis: related to disease duration? |
| Q40780194 | Clinically important ocular reactions to systemic drug therapy |
| Q41930670 | Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. |
| Q41923610 | Cystoid macular oedema and epiretinal membrane formation during progression of chloroquine retinopathy after drug cessation |
| Q41917221 | Desquamative interstitial pneumonia responsive to chloroquine |
| Q41914430 | Factors associated with chloroquine-induced retinopathy in rheumatic diseases. |
| Q42336611 | Macular edema might be a rare presentation of hydroxychloroquine-induced retinal toxicity |
| Q41917354 | Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology |
| Q33555267 | Report on chloroquine and dapsone in the treatment of rheumatoid arthritis: a 6-month comparative study |
| Q34487935 | Screening for antimalarial maculopathy in rheumatology clinics |
| Q37978096 | Screening for hydroxychloroquine retinal toxicity: is it necessary? |
| Q41002662 | The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report |
Search more.